|
Tweet | ||
285 | Tue, 8/11/2015, 8:30 AM - 10:20 AM | CC-4C3 | |
Key Subgroup Analysis Issues in Clinical Trials — Invited Papers | |||
ENAR , International Chinese Statistical Association | |||
Organizer(s): Alex Dmitrienko, Quintiles | |||
Chair(s): Alex Dmitrienko, Quintiles | |||
8:35 AM | Do Subgroup Analyses Harm? Usually Not. Are They Helpful? It Depends. A Regulatory and Practical Review — Christoph Muysers, Bayer HealthCare | ||
8:55 AM | Common Practices in Industry for Subgroups Identification and Analysis in Clinical Trials — Cristiana Mayer, Janssen R&D/Johnson & Johnson | ||
9:15 AM | Many Faces of Subgroup Analysis in Clinical Drug Development — Ilya Lipkovich, Quintiles ; Alex Dmitrienko, Quintiles | ||
9:35 AM | Discussant: Gary Koch, The University of North Carolina at Chapel Hill | ||
9:55 AM | Discussant: H.M. James Hung, FDA |
For program information, contact the JSM Registration Department or phone (888) 231-3473.
For Professional Development information, contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
2015 JSM Online Program Home
ASA Meetings Department
732 North Washington Street, Alexandria, VA 22314
(703) 684-1221 • meetings@amstat.org
Copyright © American Statistical Association.